[{"data":1,"prerenderedAt":154},["ShallowReactive",2],{"drug-warfarin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":19,"formulations":23,"regimens":101,"contraindications":136,"warnings":146,"renal":147,"monitoring":148,"interactions":149,"review":150,"examples":153},"warfarin",1,{"fa":7,"en":8},"وارفارین","Warfarin","cardiovascular",{"fa":11,"en":12},"آنتاگونیست ویتامین K","Vitamin K antagonist",[14,17],{"name":15,"market":16},"Coumadin","US",{"name":18,"market":16},"Jantoven",[20,21,7,22],"coumadin","کومادین","INR",[24,37,45,53,61,69,77,85,93],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":32,"refs":33},"tab-1","tablet","oral","1 mg tablet (scored)",{"amount":5,"unit":30,"perUnit":26,"scored":31},"mg",true,[16],[34],{"source":35,"section":36},"fda-warfarin","3",{"id":38,"form":26,"route":27,"label":39,"concentration":40,"markets":42,"refs":43},"tab-2","2 mg tablet (scored)",{"amount":41,"unit":30,"perUnit":26,"scored":31},2,[16],[44],{"source":35,"section":36},{"id":46,"form":26,"route":27,"label":47,"concentration":48,"markets":50,"refs":51},"tab-2-5","2.5 mg tablet (scored)",{"amount":49,"unit":30,"perUnit":26,"scored":31},2.5,[16],[52],{"source":35,"section":36},{"id":54,"form":26,"route":27,"label":55,"concentration":56,"markets":58,"refs":59},"tab-3","3 mg tablet (scored)",{"amount":57,"unit":30,"perUnit":26,"scored":31},3,[16],[60],{"source":35,"section":36},{"id":62,"form":26,"route":27,"label":63,"concentration":64,"markets":66,"refs":67},"tab-4","4 mg tablet (scored)",{"amount":65,"unit":30,"perUnit":26,"scored":31},4,[16],[68],{"source":35,"section":36},{"id":70,"form":26,"route":27,"label":71,"concentration":72,"markets":74,"refs":75},"tab-5","5 mg tablet (scored)",{"amount":73,"unit":30,"perUnit":26,"scored":31},5,[16],[76],{"source":35,"section":36},{"id":78,"form":26,"route":27,"label":79,"concentration":80,"markets":82,"refs":83},"tab-6","6 mg tablet (scored)",{"amount":81,"unit":30,"perUnit":26,"scored":31},6,[16],[84],{"source":35,"section":36},{"id":86,"form":26,"route":27,"label":87,"concentration":88,"markets":90,"refs":91},"tab-7-5","7.5 mg tablet (scored)",{"amount":89,"unit":30,"perUnit":26,"scored":31},7.5,[16],[92],{"source":35,"section":36},{"id":94,"form":26,"route":27,"label":95,"concentration":96,"markets":98,"refs":99},"tab-10","10 mg tablet (scored)",{"amount":97,"unit":30,"perUnit":26,"scored":31},10,[16],[100],{"source":35,"section":36},[102,122],{"id":103,"disease":104,"label":105,"population":108,"type":112,"unit":30,"dose":113,"refs":117},"af","atrial-fibrillation",{"fa":106,"en":107},"ضدانعقاد خوراکی — بر اساس INR","Oral anticoagulation — INR-guided",{"minAge":109},{"value":110,"unit":111},18,"year","notCalculated",{"reason":114},{"fa":115,"en":116},"دوز فردی و بر اساس INR. اگر ژنوتیپ نامعلوم است، شروع معمول ۲ تا ۵ mg یک بار در روز؛ AF غیردریچه‌ای: هدف INR ۲٫۵ (۲ تا ۳).","Individualised, INR-guided. If genotype unknown, usual start 2–5 mg once daily; non-valvular AF: target INR 2.5 (2.0–3.0).",[118,120],{"source":35,"section":119},"2.3",{"source":35,"section":121},"2",{"id":123,"disease":104,"label":124,"population":127,"type":112,"unit":30,"dose":129,"refs":133},"peds",{"fa":125,"en":126},"کودکان","Children",{"maxAge":128},{"value":110,"unit":111},{"reason":130},{"fa":131,"en":132},"مطالعه کنترل‌شده در کودکان نیست؛ دوز بهینه نامعلوم.","No controlled pediatric studies; optimum dosing unknown.",[134],{"source":35,"section":135},"8.4",[137],{"id":138,"severity":139,"text":140,"refs":143},"ci","block",{"fa":141,"en":142},"بارداری (جز دریچه مکانیکی پرخطر)؛ تمایل به خونریزی یا دیسکرازی خونی؛ جراحی اخیر یا برنامه‌ریزی‌شده CNS یا چشم (و سایر موارد بخش ۴).","Pregnancy (except high-risk mechanical valves); haemorrhagic tendencies or blood dyscrasias; recent or planned CNS or eye surgery (and other items in section 4).",[144],{"source":35,"section":145},"4",[],[],[],[],{"status":151,"reviewer":152,"date":152},"unverified",null,[],1792078541833]